Mittal A, Seshadri P S, Prasad H K, Sathish M, Nath I
Antimicrob Agents Chemother. 1983 Oct;24(4):579-85. doi: 10.1128/AAC.24.4.579.
The antileprosy effect of rifampin was evaluated by a newly developed rapid in vitro assay wherein 31 human-derived strains and 1 armadillo-derived strain of Mycobacterium leprae were maintained for 2 and 3 weeks, respectively, in murine and human macrophages in the presence of [3H]thymidine. Of these strains, 27 showed significant incorporation of the radiolabel in cultures of live bacilli as compared with control cultures of heat-killed bacilli of the same strain. Consistent and significant inhibition of [3H]thymidine uptake was observed in M. leprae resident cultures with 3 to 200 ng of rifampin per ml as compared with similar cultures without the drug. In general, an increase in percent inhibition was seen from 3 to 20 ng/ml, with marginal increases at 40, 50, and 100 ng/ml. M. leprae strains appear to be remarkably susceptible to this drug in the in vitro assay.
通过一种新开发的快速体外试验评估了利福平的抗麻风效应,其中31株人源麻风分枝杆菌菌株和1株犰狳源麻风分枝杆菌菌株分别在存在[3H]胸腺嘧啶核苷的情况下,于鼠类和人类巨噬细胞中培养2周和3周。在这些菌株中,与相同菌株的热灭活杆菌对照培养物相比,27株在活杆菌培养物中显示出放射性标记的显著掺入。与无药物的类似培养物相比,在每毫升含有3至200纳克利福平的麻风分枝杆菌常驻培养物中观察到[3H]胸腺嘧啶核苷摄取受到持续且显著的抑制。一般而言,抑制百分比从3纳克/毫升增加到20纳克/毫升,在40纳克/毫升、50纳克/毫升和100纳克/毫升时增加幅度较小。在体外试验中,麻风分枝杆菌菌株似乎对这种药物非常敏感。